CA1308355C - Implants biocompatibles - Google Patents

Implants biocompatibles

Info

Publication number
CA1308355C
CA1308355C CA 537349 CA537349A CA1308355C CA 1308355 C CA1308355 C CA 1308355C CA 537349 CA537349 CA 537349 CA 537349 A CA537349 A CA 537349A CA 1308355 C CA1308355 C CA 1308355C
Authority
CA
Canada
Prior art keywords
implant
protein
peptide
pharmaceutical
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 537349
Other languages
English (en)
Inventor
Alan H. Williams
Linton D. Staples
William J. Thiel
Richard C. Oppenheim
Iain J. Clarke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash Medical Centre
Victorian College of Pharmacy Ltd
State of Victoria
Original Assignee
Monash Medical Centre
Victorian College of Pharmacy Ltd
State of Victoria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monash Medical Centre, Victorian College of Pharmacy Ltd, State of Victoria filed Critical Monash Medical Centre
Application granted granted Critical
Publication of CA1308355C publication Critical patent/CA1308355C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 537349 1986-05-16 1987-05-19 Implants biocompatibles Expired - Lifetime CA1308355C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPH05932/86 1986-05-16
AUPH593386 1986-05-16
AUPH593286 1986-05-16
AUPH05933/86 1986-05-16

Publications (1)

Publication Number Publication Date
CA1308355C true CA1308355C (fr) 1992-10-06

Family

ID=25643094

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 537349 Expired - Lifetime CA1308355C (fr) 1986-05-16 1987-05-19 Implants biocompatibles

Country Status (4)

Country Link
EP (1) EP0270575A4 (fr)
CA (1) CA1308355C (fr)
NZ (1) NZ220325A (fr)
WO (1) WO1987006828A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332918C (fr) * 1988-07-26 1994-11-08 Colin G. Scanes Dispositifs et methodes de stimulation de la croissance des poulets gras
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
NZ286242A (en) * 1991-03-26 1997-11-24 Csl Ltd Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
US5801141A (en) * 1991-06-24 1998-09-01 American Cyanamid Company Implant compositions containing a biologically active protein, peptide or polypeptide
DE69528450T2 (de) * 1994-02-18 2003-01-23 Solidose L L C Impfung von tieren mit getrockneten pelletierten biologischen materialien
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
FR1586811A (fr) * 1966-01-06 1970-03-06
US3830907A (en) * 1968-04-22 1974-08-20 Searle & Co Compositions for the sustained release of 17alpha-ethyl-19-nortestosterone
BE792502A (fr) * 1971-12-09 1973-06-08 Upjohn Co Nouvelles formes pharmaceutiques et leur procede de preparation
FR2240718A1 (en) * 1973-08-13 1975-03-14 Aries Robert Solid implants for increasing growth of animals - contg. hormones, esters or derivs
FR2399243A2 (fr) * 1974-04-23 1979-03-02 Aries Robert Perfectionnements aux procedes, dispositifs et produits pour l'implantation d'hormones destinees a favoriser la croissance des animaux d'embouche
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
IE56979B1 (en) * 1984-02-14 1992-02-26 Drug Systems Res & Dev Subcutaneous implant
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules

Also Published As

Publication number Publication date
WO1987006828A1 (fr) 1987-11-19
EP0270575A1 (fr) 1988-06-15
NZ220325A (en) 1989-04-26
EP0270575A4 (fr) 1988-10-20

Similar Documents

Publication Publication Date Title
US5342622A (en) Subdermal biocompatible implants
EP1263416B1 (fr) Microparticules comprimees pour injection seche
EP0301856B1 (fr) Dispositif libérant des produits pharmaceutiques
EP0302582B2 (fr) Système pour la libération de drogues et son mode de préparation
US6203813B1 (en) Pharmaceutical delivery device and method of preparation therefor
EP0158277A2 (fr) Préparations implantables à libération contrôlée de peptides régulateurs et procédé pour leur fabrication
EP0293632B1 (fr) Systèmes à libération pour l'administration contrôlée d'analogues de LHRH
LV10041B (en) Microcapsules and method of producing thereof
MXPA02005911A (es) Implante farmaceutico que contiene componentes de liberacion prolongada y de liberacion sostenida y metodo para su administracion.
WO1992011843A1 (fr) Dispositifs bioerodables et compositions pour liberer par diffusion des agents actifs
WO1993007833A1 (fr) Implant biocompatible utilise pour regler l'ovulation chez des juments
PL226346B1 (pl) Kompozycja, zastosowanie kompozycji do wytwarzania leku do stosowania w obniżaniu poziomu LHRH, stały implant, zastosowanie kompozycji jako implantu o kontrolowanym uwalnianiu
US20050118271A1 (en) Polytartrate composition
CA1308355C (fr) Implants biocompatibles
CA2225796C (fr) Nouvelle formulation de liberation d'un peptide
Yoshida et al. In vivo release of testosterone from vinyl polymer composites prepared by radiation-induced polymerization
Chien et al. Microsealed drug delivery systems I: in vitro-in vivo correlation on subcutaneous release of desoxycorticosterone acetate and prolonged hypertensive animal model for cardiovascular studies
JPH01500899A (ja) 生物適合性インプラント
AU6263800A (en) Gonadotropin releasing hormone antagonist
AU1843899A (en) Novel formulation for peptide release
AU2803592A (en) Biocompatible implant for the timing of ovulation in mares

Legal Events

Date Code Title Description
MKLA Lapsed